Advertisement
SKIP ADVERTISEMENT
You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load.
Supported by
SKIP ADVERTISEMENT
F.D.A. Releases Results from Major Infant Formula Safety Study
The agency said the analysis of more than 300 formula samples was reassuring, but outside experts raised some concerns.
Listen
· 7:47 min
Share full article
Credit...
Kayana Szymczak for The New York Times
By
Alice Callahan
April 29, 2026,
8:57 a.m. ET
See more of our coverage in your search results.
Encuentra más de nuestra cobertura en los resultados de búsqueda.
Add The New York Times on Google
Agrega The New York Times en Google
When the Food and Drug Administration announced “
Operation Stork Speed
” in March 2025, it vowed to improve the safety and quality of U.S. infant formulas — in part by increasing its testing of them for heavy metals, pesticides and other contaminants.
Now, the first round of test results are in, and while federal health officials are describing them as reassuring, some outside experts say they raise questions.
Between 2023 and 2025, the agency purchased more than 300 infant formula samples from stores and online retailers and tested them for heavy metals (lead, arsenic, cadmium and mercury), pesticides, phthalates (chemicals commonly found in plastics) and PFAS (or per- and polyfluoroalkyl substances, sometimes called “
forever chemicals
”).
The agency reported that the levels of all contaminants were low, and the formulas were safe. But after looking at the raw data, a few outside experts noted that some phthalate and PFAS levels were concerning.
“Any detection of PFAS or phthalates is problematic” and deserves scrutiny, especially in products that babies consume, said Dr. Sheela Sathyanarayana, a professor of pediatrics at the University of Washington.
It’s reassuring that the heavy metal and pesticide levels were low, experts said. And it’s good that the agency is evaluating these contaminants, Dr. Sathyanarayana said. But, she added, the findings highlight the need for continued monitoring and work to reduce levels of them in formula.
Thank you for your patience while we verify access. If you are in Reader mode please exit and
log into
your Times account, or
subscribe
for all of The Times.
Thank you for your patience while we verify access.
Already a subscriber?
Log in
.
Want all of The Times?
Subscribe
.
Related Content
Advertisement
SKIP ADVERTISEMENT
댓글
0